SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO) today reported financial results for the three and six months ended June 30, 2007. Total revenue for the three and six months ended June 30, 2007 was $495,577 and $999,479, respectively, as compared to $662,690 and $1,360,683, respectively, for the same periods in 2006. Revenue consisted of license fees, milestone payments, revenue recognized from collaborative research and development arrangements and grants.
